Ajanta releases Omeprazole and Sodium Bicarbonate Powder for Oral Suspension in U.S.
Omeprazole and Sodium Bicarbonate Powder for Oral Suspension is part of Ajanta’s expanding profile of products that the company has developed specifically for the U.S. market. Ajanta has 26 Abbreviated New Drug Applications (ANDAs) submitted to the U.S. Food and Drug Administration.
Of these ANDAs, 14 are on final approval, two have tentative approval and 10 remain under review.